NCT07623031

Brief Summary

This pilot study is a single-arm clinical feasibility trial evaluating the feasibility, acceptability, and preliminary efficacy of a brief adaptation of Mindfulness-Oriented Recovery Enhancement (B-MORE) for reducing stress and high blood pressure in hypertensive English- and Spanish-speaking patients (n=20). The intervention, a 2-hour online training in stress management and hypertension, will be delivered virtually in a small-group format over two 60-minute sessions.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
6mo left

Started Jun 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress8%
Jun 2026Dec 2026

First Submitted

Initial submission to the registry

May 5, 2026

Completed
27 days until next milestone

Study Start

First participant enrolled

June 1, 2026

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 3, 2026

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

June 3, 2026

Status Verified

May 1, 2026

Enrollment Period

5 months

First QC Date

May 5, 2026

Last Update Submit

June 1, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Feasibility of the B-MORE intervention for Stress

    The feasibility of the B-MORE intervention for managing stress in hypertensive patients will be assessed using recruitment metrics. Specifically, feasibility will be based on the recruitment rate, defined as the number of participants recruited and enrolled per week. Feasibility will also be based on session attendance metrics, defined as the percentage of participants who complete the first B-MORE session and the second B-MORE session. Finally, feasibility will be based on retention rates, defined as the percentage of participants completing all treatment sessions and study surveys.

    The expected time frame is from baseline to study completion, an average of 10 weeks.

  • Feasibility of the B-MORE intervention for Blood Pressure

    The feasibility of the B-MORE intervention for managing blood pressure in hypertensive patients will be assessed using recruitment metrics. Specifically, feasibility will be based on the recruitment rate, defined as the number of participants recruited and enrolled per week. Feasibility will also be based on session attendance metrics, defined as the percentage of participants who complete the first B-MORE session and the second B-MORE session. Finally, feasibility will be based on retention rates, defined as the percentage of participants completing all treatment sessions and study surveys.

    The expected time frame is from baseline to study completion, an average of 10 weeks.

Secondary Outcomes (4)

  • Treatment Acceptability for the B-MORE intervention for Stress

    Measured through participant self-report at the completion of the B-MORE program (immediately post-intervention and at 2-week and 6-week follow-up assessments).

  • Treatment Acceptability for the B-MORE intervention for Blood Pressure

    Measured through participant self-report at the completion of the B-MORE program (immediately post-intervention and at 2-week and 6-week follow-up assessments).

  • Treatment Expectancy for the B-MORE Intervention

    Measured through participant self-report at the completion of the B-MORE program (immediately post-intervention).

  • Treatment Satisfaction with the B-MORE Intervention

    Measured through participant self-report at the completion of the B-MORE program (immediately post-intervention and at the 2- and 6-week follow up points).

Other Outcomes (9)

  • Change in Psychological Stress (Physiological)

    Expected time frame is baseline to study completion, approximately 10 weeks. Heart rate and stress-related measures recorded daily.

  • Adverse Effects of the B-MORE Intervention

    Measured through participant self-report at the completion of the B-MORE program (immediately post-intervention).

  • Change in Diastolic Blood Pressure

    Measured at baseline, before and after each intervention session, immediately post-intervention, and at 2-week and 6-week follow-up assessments. Daily BP measurements will also be taken.

  • +6 more other outcomes

Study Arms (1)

B-MORE (Brief Mindfulness-Oriented Recovery Enhancement)

EXPERIMENTAL

Participants will receive a remotely-delivered mindfulness-based intervention (B-MORE) consisting of two 60-minute small group sessions conducted over two weeks. The intervention includes mindfulness training, cognitive reappraisal, and positive emotion regulation techniques.

Behavioral: Behavioral: B-MORE (Brief Mindfulness-Oriented Recovery Enhancement)

Interventions

B-MORE is a validated, two-hour adaptation of the evidence-based MORE program. It retains each of the three, core therapeutic elements of the traditional MORE program (mindfulness, reappraisal, savoring) and is organized for delivery in two, 1-hour sessions.

B-MORE (Brief Mindfulness-Oriented Recovery Enhancement)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥18
  • Having self-reported hypertension (BP ≥ 140/90)
  • Understanding English or Spanish instructions fluently

You may not qualify if:

  • Known or planned pregnancy in the next 3 months assessed via self-report
  • Cognitive impairment preventing completion of study procedures.
  • Have previous, formal mindfulness training (e.g., MBSR)
  • Other unstable illness judged by medical staff to interfere with study involvement.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shepherd's Hope Downtown Clinic

Orlando, Florida, 32805, United States

Location

MeSH Terms

Conditions

Hypertension

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Central Study Contacts

Adam Hanley, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 5, 2026

First Posted

June 3, 2026

Study Start

June 1, 2026

Primary Completion (Estimated)

November 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

June 3, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will share

Individual participant data will be shared with qualified individuals upon request.

Locations